EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Phytochemicals Targeting BDNF Signaling for Treating Neurological Disorders

Alka Ashok Singh iD, Shweta Katiyar, Minseok Song

Brain Sciences · 27.02.2025 · 15 (3) · 252

DOI: 10.3390/brainsci15030252 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Brain Sciences, online erschienen am 27.02.2025. Verfasst von Alka Ashok Singh und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Life Sciences, Yeungnam University, Gyeongsan 38541, Republic of Korea. Die Arbeit wurde bisher 58-mal zitiert (Crossref) und nennt 215 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: 2024 Yeungnam University Research Grants.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Neurological disorders are defined by a deterioration or disruption of the nervous system’s structure and function. These diseases, which include multiple sclerosis, Alzheimer’s disease, Parkinson’s disease, Huntington’s disease, and schizophrenia, are caused by intricate pathological processes that include excitotoxicity, neuroinflammation, oxidative stress, genetic mutations, and compromised neurotrophic signaling. Although current pharmaceutical treatments relieve symptoms, their long-term efficacy is limited due to adverse side effects and weak neuroprotective properties. However, when combined with other neuroprotective drugs or adjunct therapy, they may offer additional benefits and improve treatment outcomes. Phytochemicals have emerged as attractive therapeutic agents due to their ability to regulate essential neurotrophic pathways, especially the brain-derived neurotrophic factor (BDNF) signaling cascade. BDNF is an important target for neurodegenerative disease (ND) treatment since it regulates neuronal survival, synaptic plasticity, neurogenesis, and neuroprotection. This review emphasizes the molecular pathways through which various phytochemicals—such as flavonoids, terpenoids, alkaloids, and phenolic compounds—stimulate BDNF expression and modulate its downstream signaling pathways, including GSK-3β, MAPK/ERK, PI3K/Akt/mTOR, CREB, and Wnt/β-catenin. This paper also highlights how phytochemical combinations may interact to enhance BDNF activity, offering new therapeutic options for ND treatment. Despite their potential for neuroprotection, phytochemicals face challenges related to pharmacokinetics, blood–brain barrier (BBB) permeability, and absorption, highlighting the need for further research into combination therapies and improved formulations. Clinical assessment and mechanistic understanding of BDNF-targeted phytotherapy should be the main goals of future studies. The therapeutic efficacy of natural compounds in regulating neurotrophic signaling is highlighted in this review, providing a viable approach to the prevention and treatment of NDs.

Schlagwörter

Stichwörter der Autor:innen

BDNF signalingneurological disordersneurotrophinsphytochemicals

Autor:innen und Institutionen

  • Department of Life Sciences, Yeungnam University, Gyeongsan 38541, Republic of Korea.
  • Department of Botany, SBN Government PG College, Barwani 451551, MP, India.

ORCID-Profile: Alka Ashok Singh

Förderung

  • 2024 Yeungnam University Research Grants

Zitieren

APA

Singh, A. A., Katiyar, S., & Song, M. (2025). Phytochemicals Targeting BDNF Signaling for Treating Neurological Disorders. Brain Sciences, 15(3), 252. https://doi.org/10.3390/brainsci15030252

Vancouver

Singh AA, Katiyar S, Song M. Phytochemicals Targeting BDNF Signaling for Treating Neurological Disorders. Brain Sciences. 2025;15(3):252. doi:10.3390/brainsci15030252

BibTeX
@article{Singh2025,
  author = {Singh, Alka Ashok and Katiyar, Shweta and Song, Minseok},
  title = {Phytochemicals Targeting BDNF Signaling for Treating Neurological Disorders},
  journal = {Brain Sciences},
  year = {2025},
  volume = {15},
  number = {3},
  pages = {252},
  doi = {10.3390/brainsci15030252}
}
Kostenlos starten →